New Mount Sinai research tracks effects of addictive drugs on brainMay 16, 2008Mount Sinai researchers may have unlocked the key to better understanding the effect addictive drugs have on the human brain. Researchers have just published the new breakthrough study, "Design Logic of a Cannabinoid Receptor Signaling Network that Triggers Neurite Outgrowth," in the latest issue of Science on May 16th, 2008. "The research findings give us a new window into the brain, helping us to better understand the role addictive drugs have on the inner workings of brain cells ," said Ravi Iyengar Ph.D., study author and Dorothy H. and Lewis Rosenstiel Professor and Chair, Department of Pharmacology and Systems Therapeutics at Mount Sinai School of Medicine. "This type of research provides may clues for targets within brain cells against which drugs that block addiction may be targeted." Mount Sinai researchers looked at the systems biology approach in order to study molecular networks underlying addiction. The findings start to unravel the complex interactions within brain cells, which are involved in processing signals from receptors in the brain that recognize the addictive drugs. Researchers discovered that a drug that works through the cannabinoid 1 receptor recognizing the active ingredient of marijuana activates many different transcription factors, triggering the differentiation of neurons, causing permanent changes in a person's brain. Another result of study was the discovery of a new role of the breast cancer gene BRCA 1 in neuronal differentiation and the effects of addictive drugs upon them.
The Mount Sinai Hospital / Mount Sinai School of Medicine | ||||||||||
|
Related Addictive Drugs News Articles Gene therapy reduces cocaine use in rats Researchers at the U.S. Department of Energy's Brookhaven National Laboratory have shown that increasing the brain level of receptors for dopamine, a pleasure-related chemical, can reduce use of cocaine by 75 percent in rats trained to self-administer it. Assembling the jigsaw puzzle of drug addiction Using an integrative meta-analysis approach, researchers from the Center for Bioinformatics at Peking University in Beijing have assembled the most comprehensive gene atlas underlying drug addiction and identified five molecular pathways common to four different addictive drugs. How does the opioid system control pain, reward and addictive behavior? The opioid system controls pain, reward and addictive behaviors. Opioids exert their pharmacological actions through three opioid receptors, mu, delta and kappa whose genes have been cloned (Oprm, Oprd1 and Oprk1, respectively). Research elucidates mechanism by which gene expression may be altered in drug addiction Dr. Judith A. Potashkin, Ph.D. and her colleagues at Rosalind Franklin University of Medicine and Science recently completed a study investigating one of the changes in gene expression that occurs when individuals take addictive drugs. Nicotinic receptors may be important targets for treatment of multiple addictions For years, scientists have known that some people are biologically more susceptible to drug addiction than others, but they have only been able to speculate why. Morphine Makes Lasting - and Surprising - Change in the Brain Morphine, as little as a single dose, blocks the brain's ability to strengthen connections at inhibitory synapses, according to new Brown University research published in Nature. Brain's reward circuit activity ebbs and flows with a woman's hormonal cycle Fluctuations in sex hormone levels during women's menstrual cycles affect the responsiveness of their brains' reward circuitry, an imaging study at the National Institute of Mental Health (NIMH), a component of the National Institutes of Health (NIH), has revealed. Brain's reward circuit activity ebbs and flows with a woman's hormonal cycle Fluctuations in sex hormone levels during women's menstrual cycles affect the responsiveness of their brains' reward circuitry, an imaging study at the National Institute of Mental Health (NIMH), a component of the National Institutes of Health (NIH), has revealed. Adolescent smokers have a greater risk of developing alcohol-use disorders than nonsmokers Both academic studies and casual observation support the view that smokers tend to drink, and drinkers tend to smoke. New research using nationally representative data from the U.S. finds that smokers - particularly adolescent smokers - clearly have a greater vulnerability to alcohol-use disorders (AUDs) than do non-smokers. Pleasure and pain: Study shows brain's 'pleasure chemical' is involved in response to pain too For years, the brain chemical dopamine has been thought of as the brain's "pleasure chemical," sending signals between brain cells in a way that rewards a person or animal for one activity or another. More Addictive Drugs News Articles |
||||||||||
|
||||||||||